ArticleAAPS open2026
Real-time in vivo tracking of nanoparticulate vaccines in inguinal lymph nodes.
Article in AAPS open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding the kinetics of nanoparticle vaccine drainage to the lymph nodes and their residence time in these tissues is critical in vaccine development. Evaluating these parameters using conventional techniques is expensive, time-consuming, and often leads to variable data, as several animals at different time points need to be sacrificed, and lymph nodes need to be harvested for characterization. Here, we adapted an abdominal window chamber for intravital imaging of the lymph nodes, enabling real-time tracking of ionizable lipid nanoparticles (LNPs) and polymeric nanoparticles in live mice following intramuscular administration. To mimic delivery of vaccine payloads, these nanoparticles were encapsulated with luciferase mRNA or a small molecule fluorophore, indocyanine green, and tracked for bioluminescence and fluorescence, respectively, in the lymph nodes. The results demonstrated differential lymph node drainage kinetics and retention for LNPs and polymeric nanoparticles. Notably, variations in the ionizable lipid components of LNPs resulted in changes in the mRNA translation ability within the lymph nodes. Taken together, this study introduces a valuable tool to optimize nanoparticle vaccine design in preclinical studies. Graphical Abstract: Real-time in vivo tracking of the lymph node drainage kinetics of nanoparticles encapsulating mRNA or small molecule fluorescent dye, facilitated by the use of a lymph node window chamber. Created in BioRender. https://BioRender.com/786dnai. Supplementary Information: The online version contains supplementary material available at 10.1186/s41120-026-00163-5.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.